COVID‐19 vaccination status and disease burden in patients with sickle cell disease
- 4 September 2022
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 199 (4) , E21-E24
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell diseaseBlood Advances, 2021
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19New England Journal of Medicine, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infectionBlood Advances, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patientsHaematologica, 2020
- Susceptibility to invasive bacterial infections in children with sickle cell diseasePediatric Blood & Cancer, 2010
- Infection in sickle cell disease: A reviewInternational Journal of Infectious Diseases, 2010
- Global epidemiology of haemoglobin disorders and derived service indicatorsBulletin of the World Health Organization, 2008
- Management of Sickle Cell DiseaseNew England Journal of Medicine, 1999